OpenAI has taken action to block deepfake videos of Martin Luther King Jr. on its Sora app after complaints from his estate. The decision follows the rise of offensive and disrespectful portrayals, highlighting concerns over AI ethics and intellectual property.
In a significant announcement, President Trump is set to reveal a new drug pricing deal with AstraZeneca, following a similar agreement with Pfizer. This move aims to lower U.S. drug prices and pressure major drugmakers to bring manufacturing back to America. Will it lead to real savings for taxpayers?
In a bold move to reduce U.S. prescription drug prices, AstraZeneca and Pfizer have struck deals with the White House, promising significant discounts for patients. This comes amid rising pressure from President Trump on drugmakers to lower costs or face hefty tariffs. Will these changes truly benefit American patients?
Last week was a disaster for our NFL predictions, but can the Eagles reclaim their glory this week? Discover the latest picks and betting insights for this week's matchups!
In a thrilling Week 5, the Houston Texans' C.J. Stroud threw for 245 yards and four touchdowns, leading to a major team upgrade while the Patriots gear up for an easier schedule ahead. Discover the key takeaways and betting insights!
As the NFL season heats up, we break down this week's power rankings. From the Lions' resurgence to the Chiefs' struggles, discover which teams are rising and which are falling!
NFL Week 5 brought thrilling upsets and dramatic comebacks, with standout performances and key victories shaping the season. Discover how teams like the 49ers and Colts made headlines this week!
OpenAI's Sora app makes waves with 164,000 downloads in just two days, landing at No. 1 on the U.S. App Store despite being invite-only. Discover why consumers are clamoring for AI video tools!
Get ready for UFC 320! Magomed Ankalaev faces Alex Pereira in a highly anticipated rematch. Will Pereira reclaim his title? Expert predictions and insights included!
Pfizer's unexpected deal with the Trump administration on drug pricing sends shockwaves through the pharmaceutical industry, pressuring competitors to follow suit amidst potential regulatory threats. What’s next for drug prices?
